CASI Pharmaceuticals Files 6-K, Incorporates Exhibits
Ticker: CASIF · Form: 6-K · Filed: May 20, 2025 · CIK: 1962738
Sentiment: neutral
Topics: sec-filing, form-6k, registration-statement
TL;DR
CASI Pharma filed a 6-K on 5/20/25, incorporating exhibits into its F-3 registration. Old name was CASI Pharma Holdings.
AI Summary
CASI Pharmaceuticals, Inc. filed a Form 6-K on May 20, 2025, incorporating by reference information from Exhibits 99.1 and 99.2 into its Registration Statements on Form F-3 (File No. 333-283998). The company, previously known as CASI Pharmaceuticals Holdings, Inc. until January 18, 2023, is based in Beijing, China.
Why It Matters
This filing indicates ongoing regulatory and corporate actions for CASI Pharmaceuticals, potentially impacting its stock and investor relations.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates previously submitted information, not announcing new material events.
Key Numbers
- 001-41666 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- CASI Pharmaceuticals, Inc. (company) — Filer
- CASI Pharmaceuticals Holdings, Inc. (company) — Former company name
- 20250520 (date) — Filing date
- 333-283998 (document_id) — Form F-3 File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes to its security holders.
What is being incorporated by reference in this filing?
Exhibits 99.1 and 99.2 are being incorporated by reference into the Company's Registration Statements on Form F-3 (File No. 333-283998).
When did CASI Pharmaceuticals change its name?
The company changed its name from CASI Pharmaceuticals Holdings, Inc. on January 18, 2023.
Where is CASI Pharmaceuticals, Inc. located?
The company's principal executive office is located at 1701-1702, China Central Office Tower 1, No. 81 Jianguo Road, Chaoyang District, Beijing, 100025, People's Republic of China.
What is the SIC code for CASI Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for CASI Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 20, 2025 regarding CASI Pharmaceuticals, Inc. (CASIF).